NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 00074-4382-20 — Cisatracurium injection (ICU use, intravenous)AI (334 hospitals, 50,242–51,376 samples)
• NDC 67457-0228-00 — Rocuronium bromide injection, 50 mg vialAI (267 hospitals, 50,089–51,313 samples)
• NDC 72078-0034-01 — Remifentanil injection, 1 mg/mL vialAI (390 hospitals, 50,057–51,290 samples)
• NDC 70860-0701-03 — Ketorolac 30 mg/mL injectionAI (311 hospitals, 48,310–51,226 samples)
• NDC 61314-0656-05 — Ciprofloxacin 0.3% eye dropsAI (708 hospitals, 49,589–51,218 samples)
• NDC 55150-0439-01 — Ketamine injection, 50 mg per mL syringeAI (273 hospitals, 50,185–51,112 samples)
• NDC 65219-0056-29 — Potassium phosphate intravenous solutionAI (199 hospitals, 50,219–51,110 samples)
• NDC 63323-0881-16 — Sodium phosphates IV solutionAI (456 hospitals, 50,392–50,986 samples)
• NDC 00517-8005-25 — Zinc sulfate intravenous solutionAI (204 hospitals, 50,153–50,963 samples)
• NDC 63256-0100-30 — Sterile talc powder, 4 gram aerosol canisterAI (409 hospitals, 50,117–50,963 samples)
• NDC 00409-4902-64 — Dextrose 50% injectionAI (213 hospitals, 50,015–50,960 samples)
• NDC 70121-1712-01 — Dexmedetomidine IV infusion in salineAI (203 hospitals, 50,066–50,957 samples)
• NDC 00781-3040-95 — Pyridostigmine bromide injectionAI (620 hospitals, 50,136–50,928 samples)
• NDC 63323-0692-10 — Acetylcysteine 20% solution vialAI (478 hospitals, 50,011–50,920 samples)
• NDC 00409-7083-01 — Cisatracurium 2 mg/mL intravenous injectionAI (45 hospitals, 50,010–50,910 samples)
• NDC 43598-0975-11 — Dexmedetomidine IV infusion in salineAI (142 hospitals, 50,010–50,910 samples)
• NDC 00409-3307-11 — Acetylcysteine 10% solutionAI (84 hospitals, 50,010–50,910 samples)
• NDC 70121-1189-01 — Sodium nitroprusside intravenous solutionAI (47 hospitals, 50,010–50,910 samples)
• NDC 71288-0713-21 — Cisatracurium 10 mg/mL intravenous solutionAI (232 hospitals, 49,756–50,908 samples)
• NDC 00781-3220-75 — Rocuronium bromide injection, 50 mg vialAI (240 hospitals, 49,912–50,884 samples)
• NDC 14789-0011-01 — Isoproterenol injection, 0.2 mg/mL solutionAI (223 hospitals, 49,919–50,873 samples)
• NDC 00517-9203-25 — Pediatric trace element solution (zinc, copper, manganese, chromium) for IV useAI (199 hospitals, 50,045–50,873 samples)
• NDC 67457-0475-00 — Vecuronium bromide 20 mg injectionAI (167 hospitals, 50,025–50,871 samples)
• NDC 69918-0731-01 — Isoproterenol injection, 0.2 mg/mL solutionAI (118 hospitals, 50,022–50,850 samples)
• NDC 08065-1839-05 — Chondroitin and hyaluronate eye injection syringeAI (465 hospitals, 49,720–50,845 samples)
• NDC 69918-0731-10 — Isoproterenol injection, 0.2 mg/mL solutionAI (141 hospitals, 50,002–50,830 samples)
• NDC 00781-7516-14 — Budesonide 0.5 mg/2 mL nebulizer suspensionAI (101 hospitals, 50,002–50,830 samples)
• NDC 00703-2914-01 — Vecuronium injection, a muscle relaxant used in surgeryAI (162 hospitals, 50,000–50,810 samples)
• NDC 00074-1040-08 — Beractant intratracheal suspension (lung surfactant)AI (251 hospitals, 49,843–50,797 samples)
• NDC 17238-0900-30 — Fluorescein sodium eye test stripsAI (399 hospitals, 49,814–50,696 samples)
• NDC 2751201 — Insulin lispro 50/50 mixture vialAI (73 hospitals, 50,674–50,692 samples)
• NDC 76329-3390-01 — Lidocaine hydrochloride injection, 100 mg per 5 mL syringeAI (1076 hospitals, 44,104–50,620 samples)
• NDC 70092-1310-46 — Methohexital injection, 10 mg/mL syringeAI (283 hospitals, 49,606–50,596 samples)
• NDC 00517-2051-25 — Potassium phosphate injection, intravenous solutionAI (155 hospitals, 49,764–50,592 samples)
• NDC 00517-2051-01 — Potassium phosphate IV solutionAI (155 hospitals, 49,764–50,592 samples)
• NDC 00517-9305-01 — Intravenous trace element mineral solutionAI (583 hospitals, 49,007–50,591 samples)
• NDC 00409-6729-23 — Magnesium sulfate IV solutionAI (621 hospitals, 47,206–50,590 samples)
• NDC 63323-0691-30 — Acetylcysteine 10% solution vialAI (288 hospitals, 49,678–50,578 samples)
• NDC 00409-4900-14 — Sodium bicarbonate 8.4% IV solutionAI (294 hospitals, 49,830–50,577 samples)
• NDC 76045-0009-06 — Dilaudid 1 mg/mL injectionAI (804 hospitals, 38,408–50,540 samples)
• NDC 00409-1634-01 — Vecuronium bromide 20 mg injectionAI (135 hospitals, 49,742–50,525 samples)
• NDC 00409-1555-54 — Hetastarch in lactated electrolyte intravenous solutionAI (162 hospitals, 49,665–50,448 samples)
• NDC 71288-0713-20 — Cisatracurium 10 mg/mL intravenous solutionAI (210 hospitals, 49,296–50,430 samples)
• NDC 00517-9302-25 — Trace minerals copper, manganese, selenium and zinc IV solutionAI (226 hospitals, 49,635–50,418 samples)
• NDC 78670-0003-67 — Dantrolene sodium 20 mg IV injectionAI (403 hospitals, 49,418–50,399 samples)
• NDC 76045-0009-96 — Hydromorphone injection syringeAI (563 hospitals, 35,022–50,385 samples)
• NDC 00409-2050-01 — Magnesium sulfate IV solution 20 g per 500 mLAI (387 hospitals, 47,745–50,337 samples)
• NDC 72266-0119-25 — Ketorolac tromethamine 60 mg/2 mL injectionAI (458 hospitals, 47,830–50,260 samples)
• NDC 00641-6018-01 — Doxapram hydrochloride injectionAI (250 hospitals, 49,491–50,211 samples)
• NDC 00517-9302-01 — Trace minerals copper, manganese, selenium and zinc IV solutionAI (245 hospitals, 49,455–50,166 samples)